{"id":"https://openalex.org/W2598060347","doi":"https://doi.org/10.1080/13543784.2017.1312339","title":"PPAR-\u03b1 agonists are still on the rise: an update on clinical and experimental findings","display_name":"PPAR-\u03b1 agonists are still on the rise: an update on clinical and experimental findings","alternate_titles":[],"publication_year":2017,"publication_date":"2017-03-27","ids":{"openalex":"https://openalex.org/W2598060347","doi":"https://doi.org/10.1080/13543784.2017.1312339","mag":"2598060347","pmid":"https://pubmed.ncbi.nlm.nih.gov/28343425"},"language":"en","primary_location":{"id":"doi:10.1080/13543784.2017.1312339","doi":"https://doi.org/10.1080/13543784.2017.1312339","is_oa":false,"landing_page_url":"https://doi.org/10.1080/13543784.2017.1312339","pdf_url":null,"source":{"id":"https://openalex.org/S131064935","display_name":"Expert Opinion on Investigational Drugs","issn_l":"1354-3784","issn":["1354-3784","1744-7658"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Opinion on Investigational Drugs","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2598060347"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5027968457","display_name":"Nicola Ferri","orcid":"https://orcid.org/0000-0001-8898-7441","observed_orcids":["https://orcid.org/0000-0001-8898-7441"]},"institutions":[{"id":"https://openalex.org/I138689650","display_name":"University of Padua","ror":"https://ror.org/00240q980","country_code":"IT","type":"education","lineage":["https://openalex.org/I138689650"]}],"countries":["IT"],"is_corresponding":true,"raw_author_name":"Nicola Ferri","raw_affiliation_strings":["Dipartimento di Scienze del Farmaco, Universit\u00e0 degli Studi di Padova, Padua, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dipartimento di Scienze del Farmaco, Universit\u00e0 degli Studi di Padova, Padua, Italy","institution_ids":["https://openalex.org/I138689650"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054743665","display_name":"Alberto Corsini","orcid":"https://orcid.org/0000-0002-9912-9482","observed_orcids":["https://orcid.org/0000-0002-9912-9482"]},"institutions":[{"id":"https://openalex.org/I189158943","display_name":"University of Milan","ror":"https://ror.org/00wjc7c48","country_code":"IT","type":"education","lineage":["https://openalex.org/I189158943"]},{"id":"https://openalex.org/I4210094922","display_name":"MultiMedica","ror":"https://ror.org/01h8ey223","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210094922","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Alberto Corsini","raw_affiliation_strings":["Dipartimento di Scienze Farmacologiche e Biomolecolari, Universit\u00e0 degli Studi di Milano, Milan, Italy","Multimedica IRCCS, Milano, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dipartimento di Scienze Farmacologiche e Biomolecolari, Universit\u00e0 degli Studi di Milano, Milan, Italy","institution_ids":["https://openalex.org/I189158943"]},{"raw_affiliation_string":"Multimedica IRCCS, Milano, Italy","institution_ids":["https://openalex.org/I4210094922"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012961676","display_name":"Cesare Riccardo Sirtori","orcid":"https://orcid.org/0000-0001-6224-5538","observed_orcids":["https://orcid.org/0000-0001-6224-5538"]},"institutions":[{"id":"https://openalex.org/I4210094195","display_name":"Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda","ror":"https://ror.org/00htrxv69","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210094195"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Cesare Sirtori","raw_affiliation_strings":["Centro Dislipidemie, A.S.S.T. Grande Ospedale Metropolitano Niguarda, Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centro Dislipidemie, A.S.S.T. Grande Ospedale Metropolitano Niguarda, Milan, Italy","institution_ids":["https://openalex.org/I4210094195"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5022387451","display_name":"Massimiliano Ruscica","orcid":"https://orcid.org/0000-0002-0195-7061","observed_orcids":["https://orcid.org/0000-0002-0195-7061"]},"institutions":[{"id":"https://openalex.org/I189158943","display_name":"University of Milan","ror":"https://ror.org/00wjc7c48","country_code":"IT","type":"education","lineage":["https://openalex.org/I189158943"]}],"countries":["IT"],"is_corresponding":true,"raw_author_name":"Massimiliano Ruscica","raw_affiliation_strings":["Dipartimento di Scienze Farmacologiche e Biomolecolari, Universit\u00e0 degli Studi di Milano, Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dipartimento di Scienze Farmacologiche e Biomolecolari, Universit\u00e0 degli Studi di Milano, Milan, Italy","institution_ids":["https://openalex.org/I189158943"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5022387451","https://openalex.org/A5027968457"],"corresponding_institution_ids":["https://openalex.org/I138689650","https://openalex.org/I189158943"],"apc_list":null,"apc_paid":null,"fwci":0.7931,"has_fulltext":false,"cited_by_count":63,"citation_normalized_percentile":{"value":0.63200815,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":96,"max":99},"biblio":{"volume":"26","issue":"5","first_page":"593","last_page":"602"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11072","display_name":"Peroxisome Proliferator-Activated Receptors","score":0.9735999703407288,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11072","display_name":"Peroxisome Proliferator-Activated Receptors","score":0.9735999703407288,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":0.01510000042617321,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13430","display_name":"Lipid metabolism and disorders","score":0.006599999964237213,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pparalpha-agonists","display_name":"PPAR\u03b1 agonist","score":0.9150000214576721},{"id":"https://openalex.org/keywords/fibrates","display_name":"fibrates","score":0.9729999899864197},{"id":"https://openalex.org/keywords/pemafibrate","display_name":"pemafibrate","score":0.9480000138282776},{"id":"https://openalex.org/keywords/wy-14643","display_name":"Wy-14,643","score":0.9399999976158142},{"id":"https://openalex.org/keywords/hypertriglyceridemia","display_name":"hypertriglyceridemia","score":0.9670000076293945},{"id":"https://openalex.org/keywords/remnant-cholesterol","display_name":"remnant cholesterol","score":0.8510000109672546},{"id":"https://openalex.org/keywords/triglyceride-rich-lipoproteins","display_name":"triglyceride-rich lipoproteins","score":0.9620000123977661},{"id":"https://openalex.org/keywords/hdl-cholesterol","display_name":"HDL cholesterol","score":0.7519999742507935},{"id":"https://openalex.org/keywords/apolipoprotein-b","display_name":"apolipoprotein B","score":0.8529999852180481},{"id":"https://openalex.org/keywords/cardiovascular-risk","display_name":"cardiovascular risk","score":0.6119999885559082},{"id":"https://openalex.org/keywords/drug-adverse-events","display_name":"drug adverse events","score":0.593999981880188},{"id":"https://openalex.org/keywords/drug-drug-interactions","display_name":"drug-drug interactions","score":0.8050000071525574},{"id":"https://openalex.org/keywords/gemfibrozil","display_name":"gemfibrozil","score":0.7080000042915344},{"id":"https://openalex.org/keywords/creatinine-elevation","display_name":"creatinine elevation","score":0.5120000243186951},{"id":"https://openalex.org/keywords/gallstone-formation","display_name":"gallstone formation","score":0.8920000195503235},{"id":"https://openalex.org/keywords/myopathy","display_name":"myopathy","score":0.9409999847412109}],"concepts":[{"id":"https://openalex.org/C2778670441","wikidata":"https://www.wikidata.org/wiki/Q384295","display_name":"Gemfibrozil","level":3,"score":0.8632071614265442},{"id":"https://openalex.org/C2776919658","wikidata":"https://www.wikidata.org/wiki/Q1467339","display_name":"Hypertriglyceridemia","level":4,"score":0.7505954504013062},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6253522634506226},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.5808849930763245},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5158671736717224},{"id":"https://openalex.org/C2776933373","wikidata":"https://www.wikidata.org/wiki/Q424744","display_name":"Fibrate","level":3,"score":0.486642450094223},{"id":"https://openalex.org/C2778913445","wikidata":"https://www.wikidata.org/wiki/Q186319","display_name":"Triglyceride","level":3,"score":0.45188698172569275},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.4338383376598358},{"id":"https://openalex.org/C2778163477","wikidata":"https://www.wikidata.org/wiki/Q43656","display_name":"Cholesterol","level":2,"score":0.4271640479564667},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.4264349639415741},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.4122503101825714},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.3990505337715149},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.39237844944000244},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.10744744539260864}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000960","descriptor_name":"Hypolipidemic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000960","descriptor_name":"Hypolipidemic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D002318","descriptor_name":"Cardiovascular Diseases","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D002318","descriptor_name":"Cardiovascular Diseases","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008055","descriptor_name":"Lipids","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D015195","descriptor_name":"Drug Design","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D047493","descriptor_name":"PPAR alpha","qualifier_ui":"Q000819","qualifier_name":"agonists","is_major_topic":true},{"descriptor_ui":"D050171","descriptor_name":"Dyslipidemias","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D050171","descriptor_name":"Dyslipidemias","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D058607","descriptor_name":"Fibric Acids","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D058607","descriptor_name":"Fibric Acids","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1080/13543784.2017.1312339","doi":"https://doi.org/10.1080/13543784.2017.1312339","is_oa":false,"landing_page_url":"https://doi.org/10.1080/13543784.2017.1312339","pdf_url":null,"source":{"id":"https://openalex.org/S131064935","display_name":"Expert Opinion on Investigational Drugs","issn_l":"1354-3784","issn":["1354-3784","1744-7658"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Opinion on Investigational Drugs","raw_type":"journal-article"},{"id":"pmid:28343425","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/28343425","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert opinion on investigational drugs","raw_type":"Journal Article"},{"id":"pmh:oai:www.research.unipd.it:11577/3225252","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/11577/3225252","pdf_url":null,"source":{"id":"https://openalex.org/S4306402547","display_name":"Padua Research Archive (University of Padova)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I138689650","host_organization_name":"University of Padua","host_organization_lineage":["https://openalex.org/I138689650"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G5455416403","display_name":"Aged-related obesity and chronic immuno-inflammation: understanding the relevance and pathophysiology of lactate","funder_award_id":"2015-0552","funder_id":"https://openalex.org/F4320321499","funder_display_name":"Fondazione Cariplo"}],"funders":[{"id":"https://openalex.org/F4320321499","display_name":"Fondazione Cariplo","ror":"https://ror.org/01gb56c55"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":106,"referenced_works":["https://openalex.org/W79782691","https://openalex.org/W114760929","https://openalex.org/W1519335354","https://openalex.org/W1615613652","https://openalex.org/W1707305026","https://openalex.org/W1709407542","https://openalex.org/W1871647034","https://openalex.org/W1924318177","https://openalex.org/W1933294490","https://openalex.org/W1963533730","https://openalex.org/W1971911987","https://openalex.org/W1974072575","https://openalex.org/W1983519362","https://openalex.org/W1986893531","https://openalex.org/W1987096050","https://openalex.org/W2010907499","https://openalex.org/W2019071303","https://openalex.org/W2020915011","https://openalex.org/W2021976026","https://openalex.org/W2028145176","https://openalex.org/W2032849264","https://openalex.org/W2034565459","https://openalex.org/W2036186774","https://openalex.org/W2047955620","https://openalex.org/W2048585401","https://openalex.org/W2050417821","https://openalex.org/W2051656202","https://openalex.org/W2062856054","https://openalex.org/W2067328467","https://openalex.org/W2071048602","https://openalex.org/W2071322608","https://openalex.org/W2072362233","https://openalex.org/W2074057964","https://openalex.org/W2076095448","https://openalex.org/W2080361134","https://openalex.org/W2080575646","https://openalex.org/W2090676154","https://openalex.org/W2090760184","https://openalex.org/W2092775227","https://openalex.org/W2094317359","https://openalex.org/W2100106197","https://openalex.org/W2104492370","https://openalex.org/W2105822415","https://openalex.org/W2108169164","https://openalex.org/W2111099202","https://openalex.org/W2113125886","https://openalex.org/W2114056762","https://openalex.org/W2118860915","https://openalex.org/W2124794869","https://openalex.org/W2125528229","https://openalex.org/W2127104460","https://openalex.org/W2131265209","https://openalex.org/W2135440509","https://openalex.org/W2135695509","https://openalex.org/W2137489898","https://openalex.org/W2138011449","https://openalex.org/W2140380288","https://openalex.org/W2144259092","https://openalex.org/W2148521985","https://openalex.org/W2150460597","https://openalex.org/W2151836226","https://openalex.org/W2157442811","https://openalex.org/W2159962535","https://openalex.org/W2162534590","https://openalex.org/W2164324917","https://openalex.org/W2166550394","https://openalex.org/W2166849509","https://openalex.org/W2168231835","https://openalex.org/W2186399224","https://openalex.org/W2189784675","https://openalex.org/W2191458743","https://openalex.org/W2198678228","https://openalex.org/W2219384223","https://openalex.org/W2253407701","https://openalex.org/W2253420963","https://openalex.org/W2279177089","https://openalex.org/W2280192011","https://openalex.org/W2291598045","https://openalex.org/W2312453897","https://openalex.org/W2313240267","https://openalex.org/W2315899065","https://openalex.org/W2323589075","https://openalex.org/W2330350400","https://openalex.org/W2341665659","https://openalex.org/W2398962077","https://openalex.org/W2400712338","https://openalex.org/W2410112289","https://openalex.org/W2412754298","https://openalex.org/W2419180821","https://openalex.org/W2463418512","https://openalex.org/W2465758073","https://openalex.org/W2487890137","https://openalex.org/W2493281337","https://openalex.org/W2509676484","https://openalex.org/W2519479884","https://openalex.org/W2519634482","https://openalex.org/W2534555913","https://openalex.org/W2545791861","https://openalex.org/W2549909732","https://openalex.org/W2551190796","https://openalex.org/W2562899840","https://openalex.org/W2570027368","https://openalex.org/W2574726211","https://openalex.org/W2588037944","https://openalex.org/W2903550451","https://openalex.org/W4240794548"],"related_works":["https://openalex.org/W2929809507","https://openalex.org/W3002287592","https://openalex.org/W4368377524","https://openalex.org/W2797947316","https://openalex.org/W4214806971","https://openalex.org/W4402372671","https://openalex.org/W4285023126","https://openalex.org/W2114056762","https://openalex.org/W1974212760","https://openalex.org/W4321439231"],"abstract_inverted_index":{"INTRODUCTION:":[0],"Non-fasting":[1],"plasma":[2,135],"triglyceride":[3],"(TG)":[4],"and":[5,57,63,90,143,150,164],"remnant":[6],"cholesterol":[7,9,163],"levels,":[8],"content":[10],"of":[11,22,31,78,104,123,134,173,194],"triglyceride-rich":[12],"lipoproteins,":[13],"have":[14],"been":[15,35],"suggested":[16],"to":[17,37,101,120,159,191],"be":[18],"an":[19],"additional":[20],"cause":[21],"cardiovascular":[23],"diseases;":[24],"thus,":[25],"pharmacological":[26],"TG-lowering":[27],"with":[28,108,128],"fibrates,":[29,109],"activators":[30,115],"PPAR-alpha":[32],"system,":[33],"has":[34],"linked":[36],"risk":[38],"reduction.":[39],"Areas":[40],"covered:":[41],"This":[42],"manuscript":[43],"reviews":[44],"available":[45],"evidence":[46],"on":[47],"clinical":[48,125,198],"trials":[49,83],"involving":[50],"highly":[51],"selective":[52],"PPAR-\u03b1":[53,114,146,183],"agonists":[54,147,184],"(i.e.,":[55],"pemafibrate)":[56],"drugs":[58],"used":[59],"in":[60,70,112],"the":[61,87,91,102,110,118,124,171,192],"pre-clinical":[62],"experimental":[64],"setting":[65],"(e.g.,":[66],"WY14,643).":[67],"Original":[68],"publications":[69],"English":[71],"were":[72,84],"selected,":[73],"as":[74,76,153,155],"well":[75,154],"Abstracts":[77],"international":[79],"meetings'":[80],"presentations.":[81],"Clinical":[82,93],"identified":[85],"using":[86],"clinicaltrial.gov":[88],"database":[89],"EU":[92],"Trials":[94],"Register":[95],"(clinicaltrialsregister.eu).":[96],"Expert":[97],"opinion:":[98],"In":[99],"addition":[100],"aim":[103],"improving":[105],"lipid":[106],"profile":[107],"interest":[111],"new":[113,182],"stems":[116],"from":[117],"need":[119],"overcome":[121],"some":[122],"problems":[126],"encountered":[127],"dose-dependent":[129],"adverse":[130],"events;":[131],"a":[132,187,196],"rise":[133],"creatinine,":[136],"gallstone":[137],"formation,":[138],"drug-drug":[139],"interactions":[140],"(i.e.":[141],"gemfibrozil),":[142],"myopathy.":[144],"New":[145],"improved":[148],"TG":[149,160],"HDL-C":[151],"levels":[152],"other":[156],"parameters":[157],"related":[158],"metabolism":[161],"(remnant":[162],"apoB),":[165],"without":[166],"raising":[167],"liver":[168],"enzymes.":[169],"Although":[170],"use":[172],"fibrates":[174],"is":[175],"rated":[176],"'second":[177],"choice'":[178],"by":[179],"many":[180],"clinicians,":[181],"may":[185],"offer":[186],"more":[188],"accessible":[189],"route":[190],"management":[193],"hypertriglyceridemia,":[195],"frequent":[197],"condition.":[199]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2598060347","counts_by_year":[{"year":2026,"cited_by_count":4},{"year":2025,"cited_by_count":6},{"year":2024,"cited_by_count":5},{"year":2023,"cited_by_count":5},{"year":2022,"cited_by_count":5},{"year":2021,"cited_by_count":4},{"year":2020,"cited_by_count":7},{"year":2019,"cited_by_count":10},{"year":2018,"cited_by_count":12},{"year":2017,"cited_by_count":5}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2017-04-07T00:00:00"}
